Viemed Healthcare (NASDAQ:VMD - Get Free Report) issued its earnings results on Monday. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02, Zacks reports. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.
Viemed Healthcare Stock Down 1.3 %
NASDAQ VMD traded down $0.10 on Monday, reaching $7.40. The company had a trading volume of 105,696 shares, compared to its average volume of 143,943. The firm has a 50-day moving average of $8.01 and a 200-day moving average of $8.19. Viemed Healthcare has a 1 year low of $6.21 and a 1 year high of $10.00. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The firm has a market capitalization of $288.13 million, a PE ratio of 27.41 and a beta of 1.50.
Viemed Healthcare Company Profile
(
Get Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
